| Andrea S Kuldanek, MD | |
|
235 Wealthy St Se, Grand Rapids, MI 49503-5247 | |
| (616) 840-8005 | |
| (616) 840-9642 |
| Full Name | Andrea S Kuldanek |
|---|---|
| Gender | Female |
| Speciality | Pediatric Medicine |
| Experience | 47 Years |
| Location | 235 Wealthy St Se, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093720815 | NPI | - | NPPES |
| RR250010074 | Other | MI | MEDICARE RR |
| 1403831 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P0010X | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine | 4301041190 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Free Bed Rehabilitation Hospital | 4587576541 | 109 |
News Archive
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed. Scientists at the University of Gothenburg, Sweden, have now developed a method that can be used to develop safer drugs.
Alzheimer's is a progressive form of presenile dementia that is similar to senile dementia except that it usually starts in the 40s or 50s; first symptoms are impaired memory which is followed by impaired thought and speech and finally complete helplessness
EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS).
› Verified 8 days ago
| Entity Name | Mary Free Bed Rehabilitation Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730133463 PECOS PAC ID: 4587576541 Enrollment ID: O20040116000604 |
News Archive
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed. Scientists at the University of Gothenburg, Sweden, have now developed a method that can be used to develop safer drugs.
Alzheimer's is a progressive form of presenile dementia that is similar to senile dementia except that it usually starts in the 40s or 50s; first symptoms are impaired memory which is followed by impaired thought and speech and finally complete helplessness
EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea S Kuldanek, MD 3350 Eagle Park Dr Ne, Suite 108, Grand Rapids, MI 49525-4570 Ph: (616) 458-1088 | Andrea S Kuldanek, MD 235 Wealthy St Se, Grand Rapids, MI 49503-5247 Ph: (616) 840-8005 |
News Archive
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed. Scientists at the University of Gothenburg, Sweden, have now developed a method that can be used to develop safer drugs.
Alzheimer's is a progressive form of presenile dementia that is similar to senile dementia except that it usually starts in the 40s or 50s; first symptoms are impaired memory which is followed by impaired thought and speech and finally complete helplessness
EMD Serono, Inc. an affiliate of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS).
› Verified 8 days ago
Dr. Aashish A Deshpande, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne Ste 400, Grand Rapids, MI 49503 Phone: 616-486-9600 | |
Dr. Jacob H Reisner, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Dr Se Ste 300, Grand Rapids, MI 49546 Phone: 616-267-8860 | |
Jina Libby, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 200 Jefferson Ave Se Bldg Ste 305, Grand Rapids, MI 49503 Phone: 616-685-6867 | |
Christopher Rizik, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 235 Wealthy St Se, Grand Rapids, MI 49503 Phone: 616-840-8000 | |
Dr. Eric J Egeler, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Jason Toma, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2320 E Beltline Ave Se, Grand Rapids, MI 49546 Phone: 616-831-8666 |